Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide and Rituximab Maintenance in Young High-Risk DLBCL
NCT07760610Phase 4Not yet recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Sep 2026
- Primary completion
- Jul 2028
01
Overview
A Phase 4 trial of pomalidomide in diffuse large B-cell lymphoma (DLBCL), sponsored by The First Hospital of Jilin University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
pomalidomide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT07760610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07760610.